BASILEA PHARMACEUTICA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

BASILEA PHARMACEUTICA Trademark

Serial Number: 98610677

BASILEA PHARMACEUTICA is a trademark filed by BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL on June 20, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (26 trademarks)

HEGENHEIMERMATTWEG 167B
ALLSCHWIL 4123 , CH

Entity Type: 03

Trademark Details

Filing Date

June 20, 2024

Registration Date

Not Registered

Published for Opposition

May 20, 2025

Goods & Services

diagnostic reagents for medical or veterinary purposes; pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical purposes; clinical medical reagents

chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents, other than for medical or veterinary purposes

Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 7, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jul 6, 2026 EX2G
SOU EXTENSION 2 FILED
Jul 6, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 6, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 16, 2026 EXRA
SOU EXTENSION 1 GRANTED
Jan 16, 2026 EX1G
SOU EXTENSION 1 FILED
Jan 15, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 15, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 15, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 20, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 20, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 31, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 31, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 31, 2025 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jan 25, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 14, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2025 NWOS
NEW APPLICATION ENTERED
Jun 20, 2024 NWAP